Peer-reviewedCC BY 4.0Frontiers in Immunology
Editorial: Implications of senescence in cancer immunology
- 1Department of Molecular Medicine, Laboratory Affiliated to Istituto Pasteur-Fondazione Cenci Bolognetti, Sapienza University of Rome
- 2Cancer Research UK Clinical Trials Unit, Leeds Institute of Clinical Trial Research, University of Leeds
- 3Institute of Biomedicine and Molecular Genetics (IBGM), Higher Council for Scientific Research (CSIC) - University of Valladolid (UVA)
Related
- Editorial: Immunology of human fungal pathogens: host-pathogen interactions, immune evasion, and therapeutic strategies
- DNA damage response as a driver of PD-L1 expression in cellular senescence: implications for immune evasion and immunosenescence
- Therapy-Induced Senescence in Cancer Treatment Resistance: Mechanisms, Evidence, and Translational Opportunities
- Therapy-induced senescence in breast cancer and cardiovascular disease: a double-edged biological process
- Editorial: Community series in unveiling the next generation of cancer immunity & immunotherapy in lung cancer, volume II
BibTeX
@article{zingoni2026editorial,
title = {{Editorial: Implications of senescence in cancer immunology}},
author = {Alessandra Zingoni and Gordon Cook and Laura Senovilla},
journal = {Frontiers in Immunology},
year = {2026},
month = sep,
doi = {10.3389/fimmu.2026.1998525},
url = {https://www.frontiersin.org/articles/10.3389/fimmu.2026.1998525/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Editorial: Implications of senescence in cancer immunology
AU - Alessandra Zingoni
AU - Gordon Cook
AU - Laura Senovilla
PY - 2026
DA - 2026/09/30
JO - Frontiers in Immunology
DO - 10.3389/fimmu.2026.1998525
UR - https://www.frontiersin.org/articles/10.3389/fimmu.2026.1998525/full
SN - 1664-3224
ER -